Brain Implant Startups Aim to Bring Vision Back to The Blind
Food and Drug Administration’s blessing to fast-track its vision technology, called Blindsight, through the regulatory ...
Morning Rush (Video) on MSN2d
Brain-Computer Interfaces: Neuralink's Leap Forward
The boundary between science fiction and medical reality blurs as companies like Elon Musk's Neuralink make strides in ...
STAT12d
Novo asks FDA to bar compounders from making Ozempic copies
Compounding pharmacies are typically allowed to make copies of drugs that are deemed to be in shortage by the FDA, which semaglutide has been for over two years. But Novo argued that semaglutide ...
Futurism15d
Neuralink Competitor Restores Vision in Blind Patients With Eye Implant
In September, Neuralink received a "breakthrough device" designation from the Food and Drug Administration for its "Blindsight" brain implant, which Elon Musk claims — without evidence — will ...
Yahoo16d
Neuralink Competitor Restores Vision in Blind Patients With Eye Implant
Things are looking a little brighter now. In September, Neuralink received a "breakthrough device" designation from the Food ...
WebMD17d
FDA OKs New Drug for Urinary Tract Infections
Oct. 28, 2024 –The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.
Men's Journal20d
MrBeast's Lunchly Meal Brand Reportedly Hit By FDA Complaints, Claims of Mold
Lunchly, the Lunchables-style brand of snack kits launched by YouTubers Logan Paul, Olajide "KSI" Olatunji, and Jimmy "MrBeast" Donaldson last month, is reportedly already getting dinged with ...
Business Insider20d
Iterum Therapeutics Gets FDA Approval Of Orlynvah For Treatment Of Urinary Tract Infections
(RTTNews) - Iterum Therapeutics plc (ITRM) Friday announced that the U.S. Food and Drug Administration (FDA) has approved Iterum's new drug application for Orlynvah (sulopenem etzadroxil and ...
Business Insider20d
Iterum Therapeutics Receives U.S. FDA Approval of ORLYNVAH™ (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections
ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades --Company to Host Conference Call on Monday, October 28 th ...
The Providence Journal20d
FDA recalls duloxetine, antidepressant known as Cymbalta, over possible cancerous chemical
According to the FDA, the drug was recalled because it had the "presence" of N-nitroso-duloxetine, a nitrosamine, which is a chemical that could increase the risk of cancer. The recall was issued ...
Fox Business20d
McDonald's E.Coli outbreak linked to California farm, FDA investigating
The McDonald's E. Coli bacterial outbreak has been linked to a farm in California and will be investigated by the Food and Drug Administration (FDA), per reports. Taylor Farms, based in Salinas ...